Effects of hypoxic and osmotic stress on the free D-aspartate level in the muscle of blood shell Scapharca broughtonii.

Blood shell, Scapharca broughtonii, contains large quantities of free D-aspartate comparable to free L-aspartate in its tissues. When the shell was reared in hypoxic seawater, D-aspartate as well as L-aspartate in the foot muscle decreased rapidly, and their total level became about one-fourth within 24 hr. None of the other amino acids examined showed a similar behavior, but many of them rather increased during the same period. The increase in L-alanine was especially remarkable and was almost equal to the sum of the decrease in aspartate enantiomers. When the shell that had been acclimated to hypoxic seawater for 96 hr was transferred to normoxic seawater, all the amino acid levels mostly returned to the control levels within 96 hr. In contrast to these effects of hypoxic stress, hyperosmotic stress of 150% seawater had no effect on the D- and L-aspartate levels in the same tissue. These results suggest that D-aspartate is involved in anaerobic energy metabolism of this bivalve as well as L-aspartate, whose vital role in anoxia-tolerant bivalves is well known.

Occurrence of N-methyl-L-aspartate in bivalves and its distribution compared with that of N-methyl-D-aspartate and D,L-aspartate.

The presence of N-methyl-L-aspartate (NMLA) was demonstrated in bivalves, Corbicula sandai and Tapes japonica. To our knowledge, this is the first report on the occurrence of NMLA in animal tissues. NMLA in bivalve tissues was identified according to the following findings; (a) its derivatives with (+)- and (-)- 1-(9-fluorenyl)ethyl chloroformate (FLEC) behaved identically with those of authentic NMLA, respectively, on high-performance liquid chromatography (HPLC), (b) its derivatives with (+)- and (-)- FLEC behaved identically with (-)- and (+)-FLEC derivatives of authentic N-methyl-D-aspartate (NMDA), respectively, on HPLC and (c) its behavior on thin-layer chromatography was the same as those of authentic NMLA. We also describe the distribution of NMDA, and D- and L-aspartate, to which N-methylaspartate enantiomers are structurally related. NMDA was more widely dirtributed than NMLA in bivalves. These bivalves containing NMLA showed lower D-aspartate contents and D/(D+L) ratios of aspartate, than the bivalves containing NMDA.

Purification and properties of alanine racemase from crayfish Procambarus clarkii.

Fresh water crayfish Procambarus clarkii is known to accumulate D-alanine remarkably in muscle after seawater acclimation, accompanied by an increase in alanine racemase activity. We have purified alanine racemase from crayfish muscle to homogeneity. The enzyme is a monomeric protein with a molecular mass of 58 kDa. It is highly specific to alanine and does not racemize L-serine, L-aspartate, L-glutamate, L-valine and L-arginine. The enzyme shows the highest activity at pH 9.0 in the conversion of L- to D-alanine and at pH 8.5 in the reverse conversion. Properties such as amino acid sequence, quaternary structure, pyridoxal 5'-phosphate (PLP)-dependency, pH-dependency and kinetic parameters seem to be distinct from those of the microbial alanine racemases. Various salts including NaCl at concentrations around seawater level were potently inhibitory for the activity in both of L- to -D and D- to -L direction.

Characteristics of Cyclodextrin Adsorption onto Activated Carbons.

Whereas the amount of cyclodextrin (CD) adsorbed onto the large-pore activated carbon A (AC-A) increased with the number of glucose units, the amount adsorbed onto the small-pore activated carbon B (AC-B) showed the opposite tendency. This behavior can be accounted for in terms of a molecular exclusion. It is known that a good linear relationship is obtained between the Freundlich constants log K and 1/N for hydrophobic adsorption. The adsorption of CDs onto AC-A obeyed this relation, but, because of the molecular exclusion, the plots of AC-B deviated greatly. The adsorption of CDs onto AC-A was not explainable in terms of solubility. This could be because, in the case of a solid compound, adsorbability depends on the chemical potential of the molecule in aqueous solution whereas solubility depends also on the heat of fusion of the solid. In order to estimate the relative chemical potential of CDs in water, a method based on the numbers of carbon atoms and oxygen atoms in the molecule was devised which allowed a more accurate estimation of CD adsorbability than did solubility. The mean pore diameter of AC-A increased after CD adsorption, while that of AC-B showed little change. Copyright 2000 Academic Press.

Occurrence of D-amino acids in a few archaea and dehydrogenase activities in hyperthermophile Pyrobaculum islandicum.

The contents of D-enantiomers of serine, alanine, proline, glutamate (glutamine) and aspartate (asparagine) were examined in the membrane fractions, soluble proteins and free amino acids from some species of archaea, Pyrobaculum islandicum, Methanosarcina barkeri and Halobacterium salinarium. Around 2% (D/D+L) of D-aspartate was found in the membrane fractions. In the soluble proteins, the D-amino acid content was higher in P. islandicum than that in the other archaeal cells: the concentrations in P. islandicum were 3 and 4% for D-serine and D-aspartate, respectively. High concentrations of free D-amino acids were found in P. islandicum and H. salinarium; the concentrations of D-serine (12-13%), D-aspartate (4-7%) and D-proline (3-4%) were higher than those of D-alanine and D-glutamate. This result showed a resemblance between these archaea and not bacterial, but eukaryotic cells. The presence of D-amino acids was confirmed by their digestion with D-amino acid oxidase and D-aspartate oxidase. The occurrence of D-amino acids was also confirmed by the presence of activities catalyzing catabolism of D-amino acids in the P. islandicum homogenate, as measured by 2-oxo acid formation. The catalytic activities oxidizing D-alanine, D-aspartate and D-serine at 90 degrees C were considerably high. Under anaerobic conditions, dehydrogenase activities of the homogenate were 69, 84 and 30% of the above oxidase activities toward D-alanine, D-aspartate and D-serine, respectively. Comparable or higher dehydrogenase activities were also detected with these D-amino acids as substrate by the reduction of 2, 6-dichlorophenolindophenol. No D-amino acid oxidase activity was detected in the homogenates of M. barkeri and H. salinarium.

Rat and human membrane dipeptidase: tissue distribution and developmental changes.

Distribution and developmental changes in membrane dipeptidase activity were examined in rat and human tissues. The activity to hydrolyze glycyl-D-alanine in rat and human tissues was completely or almost completely inhibited by 5 mM cilastatin, suggesting that the activity was due to membrane dipeptidase and that the contribution of leucine aminopeptidase to the activity was minor. In 8-week-old rats, the activity was high in lung, kidney, pancreas and testis, and in each pooled sample of ileal mucosa, duodenal mucosa, jejunal mucosa and adrenal mucosa. A low activity was found in spleen, liver, serum and heart. The activity in lung, kidney, adrenal and intestinal mucosa increased up to the age of 5 or 8 weeks, while that in pancreas, testis and spleen reached a maximal level at around 3 weeks and declined thereafter. The distribution profile of the enzyme in postmortem tissues of adult humans was similar to that in rat, except for an extremely low activity in lung. The enzyme was also found in serum and urine from healthy volunteers. In urine, the activity was significantly correlated to the creatinine content. No clear dependence of the activity on gender or age was observed in urine and serum.

Behaviour of urinary dipeptidase in patients with chronic renal failure.

Renal dipeptidase (EC 3.4.13.19) activity in serum and urine from healthy volunteers (n = 20), patients with diabetes (n = 18) and patients with chronic renal failure (n = 5) was measured using glycyl-D-alanine as substrate. The assay was highly specific for the enzyme and was not affected by the various aminopeptidases present in serum and urine. No difference in serum renal dipeptidase activity was observed between the groups. The enzyme activity (U/L) in urine was higher than that in serum, irrespective of the group, suggesting the urine concentration was not affected by the serum concentration. The mean renal dipeptidase activities in urine were 2.56, 2.46 and 0.78 U/mol creatinine for healthy subjects, patients with diabetes and patients with chronic renal failure, respectively. The renal dipeptidase activity was significantly lower in the chronic renal failure group. The urinary excretion of dipeptidase (U/mmol creatinine) showed significant inverse correlations with that of beta 2-microglobulin, albumin and alpha 1-microglobulin, and with serum concentrations of creatinine, beta 2-microglobulin and alpha 1-microglobulin. We suggest that urine dipeptidase may be a useful marker of renal diseases.

Determination of N-methyl-D-aspartate in tissues of bivalves by high-performance liquid chromatography.

The natural occurrence of N-methyl-D-aspartate (NMDA) is limited to the foot muscle of Scapharca broughtonii; it is a well known compound for its neuroexitatory activity. This paper describes a high-performance liquid chromatographic (HPLC) method for the determination of NMDA in biological extracts. The method involves removal of neutral and basic substances by anion-exchange chromatography and removal of acidic primary amino acids by treatment with o-phthalaldehyde before derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate, followed by HPLC with isocratic elution with a selected mobile phase that separates the two diastereomers formed. The identity of the detected NMDA has been confirmed by a procedure using (-)-1-(9-fluorenyl)ethyl chloroformate as a derivatizing agent. The identification has been further supported by the disappearance of the peak of the NMDA derivative by pretreatment of the sample with D-aspartate oxidase. Application of the method has shown the presence of NMDA in several tissues of S. broughtonii and Scapharca subcrenata.

Peroxisomal localization of D-aspartate oxidase and development of peroxisomes in the yeast Cryptococcus humicolus UJ1 grown on D-aspartate.

The peroxisomal localization of D-aspartate oxidase (EC. 1.4.3.1) was demonstrated in the yeast Cryptococcus humicolus UJ1 cells grown in the medium containing D-aspartate as a nitrogen source. The conclusion is based on the identical behavior of the enzyme with those of peroxisomal marker enzymes, catalase and urate oxidase, during all steps of subcellular fractionations. Supporting evidence was provided by the morphometric analysis of the peroxisomes with electron microscopy, showing that the cells grown on D-aspartate contained more and larger peroxisomes than those grown on L-aspartate, consistent with the 500-fold and 3-fold, higher contents of D-aspartate oxidase and catalase activities, respectively, in the former cells than the latter.

D-amino acid hydrolysing enzymes.

Only a few enzymes that hydrolyse peptide bonds involving D-amino acids effectively have been discovered and characterised in multicellular organisms. Mammalian renal dipeptidase hydrolyses various dipeptides with a D-amino acid only at the C-terminal with similar efficiency to their L-amino acid diastereomers, but not dipeptides with an N-terminal D-amino acid residue. Nor does the enzyme act on tripeptides. Dipeptides similar to those hydrolysed by the enzyme are also hydrolysed by cytosolic leucine aminopeptidase, but much less effectively than their L-amino acid diastereomers. Peptidyl-D-amino acid hydrolase from cephalopods has a somewhat broader substrate specificity than the renal dipeptidase and hydrolyses, as well, some dipeptides with a D-amino acid at the N-terminal. It also acts on larger peptides than dipeptides, albeit slowly. Carnosinase is specific to dipeptides containing L-His as the C-terminal residue, and hydrolyses D-Ala-L-His about as well as carnosine.

Occurrence of free D-aspartate and aspartate racemase in the blood shell Scapharca broughtonii.

Substantial concentrations of D-aspartate were found in several tissues of Scapharca broughtonii together with approximately equal concentrations of L-aspartate. The foot and mantle extracts also contained an aspartate racemase activity. The formation of L-aspartate from the D-enantiomer by the foot extract was apparently slower than the reverse reaction, and this unbalance seemed to be due to the presence of an enzyme activity which rapidly converted L-aspartate to L-alanine. The possible role of D-aspartate in the anaerobiosis was discussed.

Purification and kinetic properties of a D-amino-acid peptide hydrolyzing enzyme from pig kidney cortex and its tentative identification with renal membrane dipeptidase.

We previously reported the presence of an enzyme activity which hydrolyzes Gly-D-Asp in pig kidney cortex. In the present study, an enzyme which hydrolyzes this peptide and other peptides having a low number of D- and L-amino acids has been purified from the brush border membranes of the same tissue. The native enzyme, having a molecular weight of 99,000, was apparently a homodimer of a subunit with a molecular weight of 48,000 and its optimum pH was 7.8 with Gly-D-Ala as substrate. The enzyme hydrolyzed many dipeptides, but not most of the tripeptides tested with a few exceptions, from which the carboxyl-terminal amino acid was liberated by the enzyme. Of the dipeptides examined, those having a D-amino acid at the amino-terminal were poor substrates, whereas those bearing a D-amino acid at the carboxyl-terminal were good substrates, comparable with their diastereomers with a L-amino acid at the same position. The enzyme was potently inhibited by cilastatin but not by amastatin and bestatin. Metal ion chelators and dithiothreitol were also inhibitory. Comparison of the properties of present enzyme with those of other known enzymes suggests that this should be tentatively identified with renal membrane dipeptidase. The demonstrated high activity toward dipeptides containing various D-amino acids at the carboxyl-terminal suggests a possibility that the enzyme in fact plays a role in degradation in vivo of D-amino-acid-containing peptides.

Distribution of D-aspartate oxidase and free D-glutamate and D-aspartate in chicken and pigeon tissues.

The presence of D-aspartate oxidase activity and D-glutamate was demonstrated for the first time in several tissues of chicken and pigeon. 2. The identification of the enzyme was based on substrate and inhibitors specificity of the activity as well as other requirements for the activity, and the amino acid was identified with HPLC analysis. 3. In each animal, the highest activity was found in the kidney. In chicken, the hepatic, renal and pancreatic activities were significantly higher in male than female. In pigeon, however, any significant gender difference was not observed. 4. A substantial amount of D-glutamate, as well as D-aspartate, was detected in each tissue, irrespective of species. 5. The contents of the free D-enantiomers were significantly different between two genders in the chicken kidney, heart and pancreas and pigeon liver and kidney. However, any common relationship was not observed between the contents and the D-aspartate oxidase activity.

Purification and properties of D-aspartate oxidase from Cryptococcus humicolus UJ1.

D-Aspartate oxidase (EC 1.4.3.1), which is highly specific to D-aspartate, was inducibly produced by a yeast strain which was isolated from soil and identified as Cryptococcus humicolus UJ1. The enzyme was purified to homogeneity as indicated on SDS-polyacrylamide gel electrophoresis. The molecular mass of the monomer subunit was determined to be 40 kDa. The native enzyme was suggested to be a homotetramer by its behavior on gel filtration. The enzyme was shown to be a flavoprotein by its absorption spectral properties, and the flavin was found to be tightly, but not covalently, bound FAD. The purified preparation had a specific activity of 76.1 mumol/min per mg protein with D-aspartate as substrate. Optimum pH was 7.5 and optimum temperature was around 35 degrees C. D-Glutamate was a very poor substrate for the enzyme. N-Methyl-D-aspartate was better than D-glutamate as substrate but markedly poorer than D-aspartate. Malonate was the most effective competitive inhibitor of the compounds tested. The N-terminal amino-acid sequence of the enzyme showed a significant homology with those of D-aspartate oxidases from beef kidney and Octopus vulgaris and those of D-amino-acid oxidases from various sources.

D-Aspartyl residue in a peptide can be liberated and metabolized by pig kidney enzymes.

The presence of an enzyme activity which hydrolyzes glycyl-D-aspartate was found in the homogenates of pig kidney cortex. The activity was inhibited by metal chelating agents and cilastatin, suggesting that the enzyme was a cilastatin-sensitive metallo-peptidase. Of the two hydrolysis products,D-aspartate was found to be less accumulated than glycine. The fate ofD-aspartate was, therefore, examined and the amino acid was found to be converted toL-aspartate,L-alanine and pyruvate, in the presence ofL-glutamate. Experiments with enzyme inhibitors suggested that the conversion involvedD-aspartate oxidase, aspartate aminotransferase and alanine aminotransferase as well as decarboxylation of oxaloacetate produced fromD-aspartate. All the results indicate that the enzymes in the pig kidney can liberate theD-aspartyl residue in the peptide and convert it to the compounds readily utilizable. The finding suggests a probable metabolic pathway of theD-aspartate-containing peptide.

Presence of free D-glutamate and D-aspartate in rat tissues.

The presence of free D-glutamate was demonstrated for the first time in rat liver, kidney and brain. This is based on the findings that the D-glutamate as well as D-aspartate in the tissue extracts co-chromatographed exactly with the authentic standards on HPLC, and that the treatment of the extracts with D-aspartate oxidase mostly abolished the HPLC peaks of these compounds. Contents of these acidic D-amino acids in the liver and kidney, as well as the percentages of D/(D + L), were lower in female than in male, while D-aspartate oxidase activities in the same tissues were inversely lower in male than in female, in agreement with a probable role of the enzyme. A significant correlation was observed between D-aspartate and D-glutamate contents in the liver, kidney and brain of individual animals, with the D-glutamate contents always higher than the D-aspartate contents.

Gender dependence of D-aspartate oxidase activity in rat tissues.

1. A gender difference in D-aspartate oxidase activity was demonstrated for the first time in rat tissues. 2. In adult Wistar rats, the hepatic enzyme activity was constantly higher in females than males. The renal activity showed a similar tendency. 3. The gender difference in the hepatic activity was not observed in newborn animals, but became apparent with growth almost in parallel with sexual maturation. 4. The hepatic activity in females was greatly affected by pregnancy and parturition.

Presence of D-aspartate oxidase and free D-aspartate in amphibian (Xenopus laevis, Cynops pyrrhogaster) tissues.

1. This paper is the first report on the presence of D-aspartate oxidase activity and free D-aspartate in the amphibian tissues. 2. The presence of D-aspartate oxidase activity in tissues of clawed toad (Xenopus laevis) and Japanese newt (Cynops pyrrhogaster) was demonstrated by requirements for enzyme activity, selective inhibition with meso-tartrate and substrate specificity. 3. In each animal, the highest activity was found in kidney, followed by liver and brain, and no gender difference in the specific activity was observed in each tissue. 4. A small but significant amount of D-aspartate was detected in liver and kidney, irrespective of species. 5. In the newt, there was a gender difference in the hepatic and renal content of D-aspartate and not in the D-/D+L-aspartate ratio.

Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.

A single intraperitoneal injection of DL-buthionine-S,R-sulfoximine (BSO) (4 mmol/kg) to overnight-starved rats caused a 70% inhibition of hepatic gamma-glutamylcysteine synthetase and induced a decrease in liver-reduced glutathione (GSH) for several hours. There was, however, no difference in hepatic lipid peroxidation, as assessed by malondialdehyde accumulation, between the control and BSO groups. During acute ethanol intoxication (5 g/kg), hepatic lipid peroxidation was increased by approx. 40% within 6 hr. Hepatic [GSH] was also significantly decreased by ethanol. The effect of ethanol on GSH level was not observed in rats pretreated with BSO, though the ethanol-induced enhancement of hepatic lipid peroxidation was potentiated by the BSO pretreatment. Under these conditions there were no apparent effects on blood concentrations of ethanol and acetaldehyde nor on activities of hepatic alcohol dehydrogenase, aldehyde dehydrogenase, glutathione-dependent detoxifying enzymes, superoxide dismutase or catalase. These results suggest that, although a decrease (by BSO) in GSH by itself does not alter the degree of endogenous lipid peroxidation, it is associated with a potentiation of the enhancement of hepatic lipid peroxidation caused by acute ethanol intoxication.

The metabolism of acetaldehyde and not acetaldehyde itself is responsible for in vivo ethanol-induced lipid peroxidation in rats.

A single oral administration of ethanol (5 g/kg) to rats induced a marked increase in lipid peroxidation, in the liver and kidney within 9 hr, as assessed by malondialdehyde accumulation. The pretreatment with alcohol dehydrogenase (ADH) inhibitor, 4-methylpyrazole (1 mmol/kg) caused approximately 50% inhibition of the hepatic ADH activity and abolished this ethanol-induced lipid peroxidation. The disulfiram treatment (100 mg/kg) significantly inhibited 63% of the hepatic low Km aldehyde dehydrogenase (ALDH) but not the high Km ALDH. The cyanamide treatment (15 mg/kg) effectively decreased 83% of the low Km and 70% of the high Km ALDH in the liver. Although there was more than a 20-fold elevation of acetaldehyde levels by the inhibition of acetaldehyde metabolism with disulfiram or cyanamide, the ethanol-induced lipid peroxidation was significantly suppressed by pretreatment with these drugs. More than 90% inhibition of xanthine oxidase and dehydrogenase by the pretreatment with allopurinol (100 mg/kg), with no effect on the hepatic ADH and ALDH activities, did not alter the enhancement of lipid peroxidation following ethanol administration. We propose that the metabolism of acetaldehyde (probably via the low Km ALDH) and not acetaldehyde itself is responsible for the ethanol-induced lipid peroxidation in vivo and that the contribution of xanthine oxidase, as an initiator of lipid peroxidation through acetaldehyde oxidation is minute during acute intoxication.